Across TCGA pan-cancer cohorts, RPL32P6 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL32P6’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL32P6 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P6 is over-expressed in tumor, although a few such as KIRC and KICH show the opposite, repressed pattern.

KIRC, COAD, and KICH are the cancer types where RPL32P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	−0.090	<.001	7	view →
COAD	Female	All	+0.292	.005	4	view →
KICH	All	All	−0.135	.006	3	view →
CHOL	All	All	+0.165	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RPL32P6 RNA expression & survival · all RPL32P6 data types